Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05232279

Effect of Testofen on Erectile Function in an Adult Male Population

Effect of Testofen on Erectile Function in an Adult Male Population - A Double Blind, Randomised Controlled Trial.

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
RDC Clinical Pty Ltd · Industry
Sex
Male
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.

Conditions

Interventions

TypeNameDescription
DRUGTestofen 300mgTestofen in capsule form - To be taken as a 300mg dosage (2 capsules) once daily for 12 weeks.
DRUGTestofen 600mgTestofen in capsule form - To be taken as a 600mg dosage (2 capsules) once daily for 12 weeks.
DRUGPlacebo comparatorThe placebo will consist of maltodextrin and will appear identical to the Testofen capsules. The placebo will be administered as per the active treatment - 2 capsules once daily for 12 weeks.

Timeline

Start date
2022-04-19
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2022-02-09
Last updated
2025-07-24

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05232279. Inclusion in this directory is not an endorsement.